Fluorescein and fluorescein glucuronide in plasma
- 1 August 1992
- journal article
- Published by Wiley in Acta Ophthalmologica
- Vol. 70 (4) , 447-453
- https://doi.org/10.1111/j.1755-3768.1992.tb02113.x
Abstract
The evaluation of the blood‐ocular barrier for fluorescein requires the measurement of free and unconjugated fluorescein in plasma. This study introduces a new and simple method for the determination of free fluorescein in plasma on the basis of determined total free plasma fluorescense and the free fraction of fluorescence. An excellent good correlation between differential spectrofluorophotometry and this new method is demonstrated. After intravenous administration of sodium fluorescein, the contribution of fluorescein glucuronide to total free plasma fluorescence was evaluated on basis of the areas under the plasma concentration/time curves for fluorescein and fluorescein glucuronide, respectively. After 1 h 8.2% of total free fluorescence in plasma was found to originate from fluorescein glucuronide and after 24 h 18.3% originated from this metabolite. It was concluded that although plasma fluorescein glucuronide measurements are important in the exact evaluation of the blood‐ocular barrier, the contribution of fluorescein glucuronide to vitreous fluorescence after intravenous fluorescein administration seems to be of minor magnitude.Keywords
This publication has 9 references indexed in Scilit:
- Fluorescein and fluorescein glucuronide in the vitreous body of diabetic patientsAlbrecht von Graefes Archiv für Ophthalmologie, 1987
- Technical variables in vitreous fluorophotometryAlbrecht von Graefes Archiv für Ophthalmologie, 1985
- Studies on fluorescein concentration in the plasmaAlbrecht von Graefes Archiv für Ophthalmologie, 1985
- FLUORESCEIN IN HUMAN PLASMA IN VIVOActa Ophthalmologica, 1982
- Early breakdown of the blood-retinal barrier in diabetes.British Journal of Ophthalmology, 1975
- METABOLISM AND EXCRETION PATTERNS OF FLUORESCEIN AND CERTAIN HALOGENATED FLUORESCEIN DYES IN RATSThe Journal of Pharmacology and Experimental Therapeutics, 1962